NeuroFrontiers

Practical Neurology
  • 0,0 (0)
  • Biowissenschaften
  • Monatlich

Practical Neurology partners with ReachMD to bring you clinical research and advancements that further clinicians' ability to diagnose and treat neurologic conditions. 

  1. 23. Juni

    Advancing MOGAD Care

    Episode Description: What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Levy, MD, Massachusetts General Hospital, Boston, MA, discusses relapse prevention, diagnostic challenges, and the future of MOGAD management with Peter Sguigna, MD, UT Southwestern Medical Center, Dallas, TX.

    10 Min.

  2. 15. Mai

    Generalized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances

    Richard J. Nowak, MD, MS, Associate Professor of Neurology, Yale School of Medicine, Yale University, New Haven, CT and global principal investigator of the Myasthenia Gravis Inebilizumab Trial (MINT), discusses the phase 3 results, highlighting the safety and efficacy of CD19-targeted B-cell therapy for individuals with generalized myasthenia gravis and its impact on outcomes and steroid reduction in real-world practice. Additional details about MINT may be found in the following publication: The New England Journal of Medicine. For more information on the medication discussed in this episode, please refer to the Full Prescribing Information provided by Amgen, last updated 12/2025.

    16 Min.

  3. 29.10.2025

    Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis

    Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.

    14 Min.

  4. 29.10.2025

    The Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis

    Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.

    8 Min.

  5. 07.05.2025

    New Guidelines for the Assessment of Traumatic Brain Injury

    Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testing.

    21 Min.

  6. 22.03.2025

    The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions

    Jack Reeves, PhD, researcher at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, discusses results of a study which demonstrated high efficacy disease-modifying therapies may help prevent the development of paramagnetic rim lesions and slow the progression of multiple sclerosis.

    14 Min.

  7. 14.03.2025

    Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm

    Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, Cleveland, OH, discusses his work with the Parkinson’s Foundation developing new hospital care standards for reducing medication mismanagement and improper or insufficient care.

    15 Min.

  8. 22.01.2025

    Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

    Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.

    18 Min.
Alle anzeigen (13)

Info

Practical Neurology partners with ReachMD to bring you clinical research and advancements that further clinicians' ability to diagnose and treat neurologic conditions. 

Informationen

  • Erstellt von
    Practical Neurology
  • Jahre aktiv
    2024 - 2026
  • Folgen
    13
  • Bewertung
    Unbedenklich
  • Copyright
    © 2024 Bryn Mawr Communications III LLC
  • Sendungswebsite
    NeuroFrontiers

Das gefällt dir vielleicht auch